-
| Sector | Healthcare |
|---|---|
| Industry | Biotechnology |
| ISIN | None |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| Market Cap | 1B |
|---|---|
| Beta | nan |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EWTX_old using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025